Thirteen years in, Taipei's biologics summit is back for its 14th edition. Expect two days of hallway debates on titers, CDMO capacity and trial design, the kind your non-biotech friends politely change the subject on.
Organized by IMAPAC, Biologics World Taiwan brings together 300+ global and local experts across the whole biologics pipeline: manufacturing, R&D and clinical trials for biologic drugs, vaccines, and cell & gene therapies.
What's getting picked apart this year
AI-powered innovation in biologics R&D
Scaling biomanufacturing capacity with CDMO partners
Gene and cell therapy advances, including CAR-T and stem cell applications
Upstream and downstream process optimisation
Vaccine development case studies: mRNA, HIV and dengue
Taiwan's strategy for taking its biotech sector global
Why Taipei is the place for this
Taiwan wants to repeat its semiconductor story in biomedicine. That ambition sits behind moves like the Taiwan Bio-Manufacturing Corporation, which was modeled on TSMC, and a wider push for domestic CDMO capacity. If your work touches the region's supply chain, this is a room worth being in.
Check your ticket before you book
Bring the scale-up problem that's been costing you sleep. Chances are someone in Taipei has dealt with it too, and they'll happily tell you over coffee. Grab your Asian Biopharma seat and we'll see you in March.
